|
Volumn 31, Issue 1-2, 1999, Pages 1113-1114
|
Mycophenolate mofetil in combination with Tacrolimus versus neoral after liver transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISOLONE;
TACROLIMUS;
BONE MARROW TOXICITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SAFETY;
DRUG TOLERABILITY;
GASTROINTESTINAL TOXICITY;
GRAFT INFECTION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER FUNCTION;
LIVER TRANSPLANTATION;
MAINTENANCE THERAPY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
TREATMENT INDICATION;
BACTERIAL INFECTIONS;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
LIVER FUNCTION TESTS;
LIVER TRANSPLANTATION;
MYCOPHENOLIC ACID;
MYCOSES;
POSTOPERATIVE COMPLICATIONS;
PREDNISOLONE;
REOPERATION;
TACROLIMUS;
TIME FACTORS;
|
EID: 0033033182
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01925-3 Document Type: Conference Paper |
Times cited : (33)
|
References (10)
|